Error processing SSI file
Error processing SSI file
Weekly Report: Influenza Summary Update
Week ending April 9, 2005-Week 14
Error processing SSI fileThe following information may be quoted:
Synopsis:
Influenza activity in the United States peaked in early February and continued to decline during week 14 (April 3-9, 2005)*. One hundred fifty-seven (8.3%) specimens tested by U.S. World Health Organization (WHO) and National Respiratory and Enteric Virus Surveillance System (NREVSS) collaborating laboratories were positive for influenza viruses. The proportion of patient visits to sentinel providers for influenza-like illness (ILI) was below the national baseline. The proportion of deaths attributed to pneumonia and influenza has been above the epidemic threshold during the last 8 weeks. There have been 28 influenza-associated pediatric deaths reported to CDC this season. Two states reported widespread influenza activity and 3 states reported regional influenza activity. Fourteen states reported local activity and 29 states, New York City, the District of Columbia, and Puerto Rico reported sporadic activity. Arkansas reported no influenza activity.
Laboratory Surveillance*:
During week 14, WHO and NREVSS laboratories in the United States reported testing 1,892 specimens for influenza viruses, of which 157 (8.3%) were positive. Of these, 9 were influenza A(H3N2) viruses, 63 were influenza A viruses that were not subtyped, and 85 were influenza B viruses.
Since October 3, WHO and NREVSS laboratories in the United States have tested a total of 131,557 specimens for influenza viruses and 21,470 (16.3%) were positive. Among the 21,470 influenza viruses, 16,632 (77.5%) were influenza A viruses and 4,838 (22.5%) were influenza B viruses. Five thousand three hundred forty-five (32.1%) of the 16,632 influenza A viruses have been subtyped: 5,332 (99.8%) were influenza A(H3N2) and 13 (0.2%) were influenza A(H1) viruses. The percentage of specimens testing positive for influenza during the last 3 weeks (weeks 12-14) has ranged from 4.7% in the West South Central region to 20.3% in the South Atlantic region**. During weeks 12-14, the number of influenza isolates reported declined and more than 50% of isolates each week were influenza B.
Antigenic Characterization:
CDC has antigenically characterized 737 influenza viruses collected by U.S. laboratories since October 1, 2004: 6 influenza A(H1) viruses, 493 influenza A(H3N2) viruses, and 238 influenza B viruses. The hemagglutinin proteins of the influenza A(H1) viruses were similar antigenically to the hemagglutinin of the vaccine strain A/New Caledonia/20/99. One hundred fifty-one (31%) of the 493 influenza A(H3N2) isolates were characterized as antigenically similar to A/Wyoming/3/2003, which is the A/Fujian/411/2002-like (H3N2) component of the 2004-05 influenza vaccine, and 342 (69%) were characterized as A/California/7/2004-like. The number of influenza A(H3N2) viruses characterized as A/Fujian/411/2002-like and A/California/7/2004-like has been adjusted from last week抯 report to correct a computing error. One hundred sixty of the influenza B viruses isolated this season belong to the B/Yamagata lineage and were characterized as B/Shanghai/361/2002-like, which is the influenza B component recommended for the 2004-05 influenza vaccine, and 25 showed somewhat reduced titers to ferret antisera produced against B/Shanghai/361/2002. Fifty-three influenza B viruses belong to the B/Victoria lineage.
Influenza B viruses currently circulating can be divided into two antigenically and genetically distinct lineages represented by B/Yamagata/16/88 and B/Victoria/2/87 viruses. B/Yamagata lineage viruses circulated widely between 1990 and 2001, during which time B/Victoria-like viruses were not identified outside of Asia. However, between March 2001 and October 2003, B/Victoria-like viruses predominated in many countries, including the United States, and the vaccine strains were changed accordingly. While both Victoria lineage and Yamagata lineage viruses have been reported worldwide during the past year, Yamagata lineage viruses have once again become predominant.
Pneumonia and Influenza (P&I) Mortality Surveillance*:
During week 14, 8.2% of all deaths reported by the vital statistics offices of 122 U.S. cities were attributed to pneumonia or influenza. This percentage is above the epidemic threshold of 8.0% for week 14.
Influenza-Associated Pediatric Mortality*:
During week 14, one pediatric death was reported to CDC. Twenty-eight pediatric deaths have been reported to CDC from 13 states (California, Colorado, Florida, Georgia, Iowa, Maine, Massachusetts, Mississippi, New Jersey, New York, Ohio, Pennsylvania, and Vermont); all deaths were reported during January-April.
Influenza-Associated Pediatric Hospitalizations:
Laboratory-confirmed influenza-associated pediatric hospitalizations are monitored in two population-based surveillance networks?/sup>: the Emerging Infections Program (EIP) and the New Vaccine Surveillance Network (NVSN). During October 3, 2004朅pril 2, 2005, the preliminary influenza-associated hospitalization rate for children 0? years old reported by NVSN and EIP was 6.2 and 2.1 per 10,000, respectively. EIP also monitors hospitalizations in children aged 5-17 years, and the preliminary influenza-associated hospitalization rate for this age group was 0.4 per 10,000. The overall hospitalization rate reported by EIP for children aged 0-17 years was 1.0 per 10,000. In years 2000?004, the end-of-season hospitalization rate for NVSN ranged from 3.7 (2002-03) to 12 (2003-04) per 10,000 children. The 2003-04 end of season hospitalization rate for EIP was 7.8 per 10,000 children 0-4 years and 0.8 per 10,000 for children aged 5-17 years. The difference in rates between NVSN and EIP may be due to different case-finding methods and the different populations monitored. For a summary of the methods used in each system, please refer to the surveillance methods in the Flu Activity section of the CDC influenza website.
Influenza-like Illness Surveillance*:
During week 14, 1.5%唵 of patient visits to U.S. sentinel providers were due to ILI. This percentage is below the national baseline of 2.5%. Regional percentages ranged from 0.6% in the New England region to 2.9% in the East South Central region. Due to wide variability in regional level data, it is not appropriate to apply the national baseline to regional level data.
View
Chart Data
| View Full Screen
Influenza Activity as Assessed by State and Territorial Epidemiologists*:
During week 14, Delaware and Kentucky reported widespread activity. Three states (Connecticut, New York, and West Virginia) reported regional influenza activity. Fourteen states (Alaska, Arizona, Colorado, Hawaii, Indiana, Louisiana, Montana, Nevada, North Carolina, North Dakota, South Carolina, South Dakota, Utah, and Virginia) reported local activity. Twenty-eight states (Alabama, California, Florida, Georgia, Illinois, Iowa, Kansas, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Nebraska, New Hampshire, New Jersey, New Mexico, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, Tennessee, Texas, Vermont, Washington, Wisconsin, and Wyoming), New York City, the District of Columbia, and Puerto Rico reported sporadic activity. Arkansas reported no influenza activity. Idaho did not report.
--------------------------------------------------------------------------------
Report prepared: April 14, 2005
Error processing SSI file